Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by KayDayon Jan 10, 2011 10:09am
245 Views
Post# 17947547

Calm before the storm

Calm before the stormThe FDA minutes could arrive at any point now and my guess is that once received they will also announce that they are going to apply for SPA with the FDA.  It is quiet now because everyone is waiting for some sort of sign.  If we go with 30 days then they should know by next Monday, though I have found an example of the EOP2 minutes being released in as few as 21 days and as long as a few months... depends on the company and their rush to release maybe.  I would hope that volume will let us know when SCT get's news but so far they have not leaked much.
Bullboard Posts